Calhoun Lesley Ann
Director at TNGX; Officer at Global Blood Therapeutics, Inc.
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 8
- Latest May 26, 2020
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- TNGXTango Therapeutics, Inc.Director
- Global Blood Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Global Blood Therapeutics, Inc.UnusualJul 9, 2018 2018
Sold 3,295 shares at $44.19 ($146k)
Calhoun Lesley Ann, Officer
Sold 89.5% of holdings ($163k position)388 shares leftFiling
- 2 Form 4 sale Global Blood Therapeutics, Inc.UnusualAug 17, 2018 +39 days
Sold 2,004 shares at $49.88 ($100k)
Calhoun Lesley Ann, Officer
Sold 70.5% of holdings ($142k position)838 shares leftFiling
- 3 Form 4 sale Global Blood Therapeutics, Inc.UnusualFeb 12, 2019 +179 days
Sold 354 shares at $50.45 ($18k)
Calhoun Lesley Ann, Officer
Sold 25.5% of holdings ($70k position)1,032 shares left0.2x usual sizeFiling
- 4 Form 4 sale Global Blood Therapeutics, Inc.UnusualSep 11, 2019 +211 days
Sold 2,765 shares at $54.36 ($150k)
Calhoun Lesley Ann, Officer
Sold 75.7% of holdings ($199k position)887 shares left2.3x usual sizeFiling
- 5 Form 4 sale Global Blood Therapeutics, Inc.UnusualMay 12, 2020 +244 days
Sold 3,373 shares at $78.23 ($264k)
Calhoun Lesley Ann, Officer
Sold 95.6% of holdings ($276k position)154 shares left1.4x usual sizeFiling
- 6 Form 4 sale Global Blood Therapeutics, Inc.UnusualMay 18, 2020 +6 days
Sold 23,330 shares at $74.67 ($1.7M)
Calhoun Lesley Ann, Officer
Sold 99.3% of holdings ($1.8M position)154 shares left8.4x usual sizeFiling
- 7 Form 4 sale Global Blood Therapeutics, Inc.UnusualMay 26, 2020 +8 days
Sold 2,700 shares at $70.10 ($189k)
Calhoun Lesley Ann, Officer
Sold 94.6% of holdings ($200k position)154 shares left0.9x usual sizeFiling
- 8 Form 144 notice TNGXNoticeJun 5, 2024 +1471 days
Filed to sell 5,000 shares ($36k)
Calhoun Lesley Ann, Director
10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Jun 5, 2024 | TNGX | Director | Form 144 notice | 5,000 | $36k | Notice | SEC | |
| May 26, 2020 | May 28, 2020 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 2,700 | $189k | 94.6% | Unusual | SEC |
| May 18, 2020 | May 20, 2020 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 23,330 | $1.7M | 99.3% | Unusual | SEC |
| May 12, 2020 | May 13, 2020 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 3,373 | $264k | 95.6% | Unusual | SEC |
| Sep 11, 2019 | Sep 13, 2019 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 2,765 | $150k | 75.7% | Unusual | SEC |
| Feb 12, 2019 | Feb 14, 2019 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 354 | $18k | 25.5% | Unusual | SEC |
| Aug 17, 2018 | Aug 20, 2018 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 2,004 | $100k | 70.5% | Unusual | SEC |
| Jul 9, 2018 | Jul 10, 2018 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 3,295 | $146k | 89.5% | Unusual | SEC |
| Mar 5, 2018 | Mar 5, 2018 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 99 | $6k | 20.3% | Plan not stated | SEC |